Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED-METABOLIC: Vardenafil for Erectile Dysfunction in Men with Metabolic Syndrome
2008-002140-41Phase 4Completed
- Sponsor
- Bayer
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in erectile dysfunction (ED) and cardiometabolic risk (CMR) comparing Vardenafil (Levitra) with Placebo (2 arms). Primary endpoints: Efficacy of vardenafil on erectile dysfunction and Tolerability and safety of vardenafil. Started Sep 2008; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on 2008-002140-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002140-41.